You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 149 No. 6, June 1995 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLE
 This Article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Hypocarbia before surfactant therapy appears to increase bronchopulmonary dysplasia risk in infants with respiratory distress syndrome

J. S. Garland, R. K. Buck, E. N. Allred and A. Leviton
Joint Program in Neonatology, Harvard Medical School, Boston, Mass, USA.

OBJECTIVE: To determine to what extent the risk of bronchopulmonary dysplasia is affected by ventilatory management before the first dose of rescue artificial surfactant. STUDY DESIGN: Retrospective cohort study. SUBJECTS: One hundred eighty-eight low-birth-weight infants (< or = 1700 g) who received artificial surfactant therapy for respiratory distress syndrome and who were alive at 36 weeks of gestational age. OUTCOME: Bronchopulmonary dysplasia was defined by a need for supplemental oxygen to maintain an arterial saturation of 92% or more at 36 weeks of gestational age. RESULTS: Thirty-seven percent (70/188) of the cohort met study criteria for bronchopulmonary dysplasia. Early determinants significantly associated with bronchopulmonary dysplasia (given as odds ratio, 95% confidence interval) in the most parsimonious backward stepwise logistic regression model included the following: birth weight of 1000 g or less (5.1, 2.4 to 10.7), cesarean birth because of fetal distress (4.4, 1.7 to 11.4), ventilatory efficiency index of 0.15 or less before surfactant therapy (3.1, 1.4 to 6.8), arterial-alveolar oxygen ratio of 0.15 or less before surfactant therapy (2.2, 1.01 to 4.6), and a low arterial PCO2 (< or = 29 vs > or = 40 mm Hg, 5.6, 2.0 to 15.6; 30 to 39 vs > or = 40 mm Hg, 3.3, 1.3 to 8.3). The inverse relationship between hypocarbia and bronchopulmonary dysplasia persisted even in stratified analyses limited to infants with measures of cardiovascular or respiratory illness that suggested less severe manifestations of disease. CONCLUSIONS: Ventilatory management before rescue treatment with artificial surfactant therapy that result in hypocarbia may increase the risk of bronchopulmonary dysplasia. These findings suggest that early ventilatory management should not only provide adequate oxygenation but also limit hyperventilation.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Management and Outcomes of Very Low Birth Weight
Eichenwald and Stark
NEJM 2008;358:1700-1711.
FULL TEXT  

Permissive Hypercapnia in Neonates
Miller and Carlo
NeoReviews 2007;8:e345-e353.
ABSTRACT | FULL TEXT  

Evaluation and Development of Potentially Better Practices to Reduce Bronchopulmonary Dysplasia in Very Low Birth Weight Infants
Payne et al.
Pediatrics 2006;118:S65-S72.
ABSTRACT | FULL TEXT  

Are carbon dioxide detectors useful in neonates?
Molloy and Deakins
Arch. Dis. Child. Fetal Neonatal Ed. 2006;91:F295-F298.
ABSTRACT | FULL TEXT  

Risk Factors for Bronchopulmonary Dysplasia in very Low Birth Weight Newborns Treated with Mechanical Ventilation in the First Week of Life
Cunha et al.
J Trop Pediatr 2005;51:334-340.
ABSTRACT | FULL TEXT  

Hypocapnic but Not Metabolic Alkalosis Impairs Alveolar Fluid Reabsorption
Myrianthefs et al.
Am. J. Respir. Crit. Care Med. 2005;171:1267-1271.
ABSTRACT | FULL TEXT  

Hyperventilation in Head Injury: A Review
Stocchetti et al.
Chest 2005;127:1812-1827.
ABSTRACT | FULL TEXT  

How safe is intermittent positive pressure ventilation in preterm babies ventilated from delivery to newborn intensive care unit?
Tracy et al.
Arch. Dis. Child. Fetal Neonatal Ed. 2004;89:F84-F87.
ABSTRACT | FULL TEXT  

Transfer of the Active Form of Transforming Growth Factor-{beta}1 Gene to Newborn Rat Lung Induces Changes Consistent with Bronchopulmonary Dysplasia
Gauldie et al.
Am. J. Pathol. 2003;163:2575-2584.
ABSTRACT | FULL TEXT  

Partial Pressure of Carbon Dioxide in Extremely Low Birth Weight Infants Supported by Nasal Prongs Continuous Positive Airway Pressure
Nguyen et al.
Pediatrics 2003;112:e208-211.
ABSTRACT | FULL TEXT  

Statement on the Care of the Child with Chronic Lung Disease of Infancy and Childhood
Am. J. Respir. Crit. Care Med. 2003;168:356-396.
FULL TEXT  

Evaluation and Development of Potentially Better Practices to Prevent Chronic Lung Disease and Reduce Lung Injury in Neonates
Sharek et al.
Pediatrics 2003;111:e426-431.
ABSTRACT | FULL TEXT  

Effects of Volume-Guaranteed Synchronized Intermittent Mandatory Ventilation in Preterm Infants Recovering From Respiratory Failure
Herrera et al.
Pediatrics 2002;110:529-533.
ABSTRACT | FULL TEXT  

Hypocapnia
Laffey and Kavanagh
NEJM 2002;347:43-53.
FULL TEXT  

Ambient pCO2 modulates intracellular pH, intracellular oxidant generation, and interleukin-8 secretion in human neutrophils
Coakley et al.
J. Leukoc. Biol. 2002;71:603-610.
ABSTRACT | FULL TEXT  

Intratracheal Endotoxin Causes Systemic Inflammation in Ventilated Preterm Lambs
KRAMER et al.
Am. J. Respir. Crit. Care Med. 2002;165:463-469.
ABSTRACT | FULL TEXT  

Clara Cell Secretory Protein Oxidation and Expression in Premature Infants Who Develop Bronchopulmonary Dysplasia
RAMSAY et al.
Am. J. Respir. Crit. Care Med. 2001;164:155-161.
ABSTRACT | FULL TEXT  

Randomised study comparing extent of hypocarbia in preterm infants during conventional and patient triggered ventilation
Luyt et al.
Arch. Dis. Child. Fetal Neonatal Ed. 2001;84:14F-17.
ABSTRACT | FULL TEXT  

Injurious Effects of Hypocapnic Alkalosis in the Isolated Lung
LAFFEY et al.
Am. J. Respir. Crit. Care Med. 2000;162:399-405.
ABSTRACT | FULL TEXT  

Do Clinical Markers of Barotrauma and Oxygen Toxicity Explain Interhospital Variation in Rates of Chronic Lung Disease?
Van Marter et al.
Pediatrics 2000;105:1194-1201.
ABSTRACT | FULL TEXT  

Risk Factors for Chronic Lung Disease in the Surfactant Era: A North Carolina Population-based Study of Very Low Birth Weight Infants
Marshall et al.
Pediatrics 1999;104:1345-1350.
ABSTRACT | FULL TEXT  

Randomized Trial of Permissive Hypercapnia in Preterm Infants
Mariani et al.
Pediatrics 1999;104:1082-1088.
ABSTRACT | FULL TEXT  

A Three-day Course of Dexamethasone Therapy to Prevent Chronic Lung Disease in Ventilated Neonates: A Randomized Trial
Garland et al.
Pediatrics 1999;104:91-99.
ABSTRACT | FULL TEXT  

Pediatric Burns
Hansbrough and Hansbrough
Pediatr. Rev. 1999;20:117-124.
FULL TEXT  

Mainstream End-tidal Carbon Dioxide Monitoring in the Neonatal Intensive Care Unit
Rozycki et al.
Pediatrics 1998;101:648-653.
ABSTRACT | FULL TEXT  

Tidal volume effects on surfactant treatment responses with the initiation of ventilation in preterm lambs
Wada et al.
J. Appl. Physiol. 1997;83:1054-1061.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1995 American Medical Association. All Rights Reserved.